JP2022545682A5 - - Google Patents
Info
- Publication number
- JP2022545682A5 JP2022545682A5 JP2022512306A JP2022512306A JP2022545682A5 JP 2022545682 A5 JP2022545682 A5 JP 2022545682A5 JP 2022512306 A JP2022512306 A JP 2022512306A JP 2022512306 A JP2022512306 A JP 2022512306A JP 2022545682 A5 JP2022545682 A5 JP 2022545682A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- igm
- variant
- motif
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891263P | 2019-08-23 | 2019-08-23 | |
| US62/891,263 | 2019-08-23 | ||
| PCT/US2020/047495 WO2021041250A1 (en) | 2019-08-23 | 2020-08-21 | Igm glycovariants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545682A JP2022545682A (ja) | 2022-10-28 |
| JP2022545682A5 true JP2022545682A5 (https=) | 2023-08-16 |
Family
ID=74684266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512306A Ceased JP2022545682A (ja) | 2019-08-23 | 2020-08-21 | ＩｇＭグリコバリアント |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220306760A1 (https=) |
| EP (1) | EP4017533A4 (https=) |
| JP (1) | JP2022545682A (https=) |
| KR (1) | KR20220050166A (https=) |
| CN (1) | CN114269380A (https=) |
| AU (1) | AU2020337333A1 (https=) |
| BR (1) | BR112022003282A2 (https=) |
| CA (1) | CA3149350A1 (https=) |
| IL (1) | IL290253A (https=) |
| MX (1) | MX2022002239A (https=) |
| WO (1) | WO2021041250A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3560954T3 (pl) | 2014-04-03 | 2021-12-13 | Igm Biosciences, Inc. | Zmodyfikowany łańcuch J |
| IL308212A (en) | 2015-01-20 | 2024-01-01 | Igm Biosciences Inc | Tumor necrosis factor-α receptor binding molecules and their uses |
| WO2016154593A1 (en) | 2015-03-25 | 2016-09-29 | Igm Biosciences, Inc. | Multi-valent hepatitis b virus antigen binding molecules and uses thereof |
| EP3355913B1 (en) | 2015-09-30 | 2024-10-30 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| EP3356401B1 (en) | 2015-09-30 | 2020-06-24 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| MX2021014973A (es) | 2019-06-07 | 2022-04-18 | Adimab Llc | Anticuerpos anti-cd3 de alta afinidad y metodos para su generacion y uso. |
| EP4377360A4 (en) * | 2021-09-17 | 2025-10-15 | Adimab Llc | Anti-cd3 antibodies |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME00832B (me) * | 2007-03-22 | 2012-03-20 | Ucb Biopharma Sprl | Vezivni proteini uključujući antitjela, derivate antitjela i fragmente antitjela, koji specifično vezuju cd154 i njihova upotreba |
| CA2780221A1 (en) * | 2009-11-04 | 2011-05-12 | Fabrus Llc | Methods for affinity maturation-based antibody optimization |
| PL3560954T3 (pl) * | 2014-04-03 | 2021-12-13 | Igm Biosciences, Inc. | Zmodyfikowany łańcuch J |
| EP3355913B1 (en) * | 2015-09-30 | 2024-10-30 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| WO2017106462A1 (en) * | 2015-12-18 | 2017-06-22 | Biogen Ma Inc. | Bispecific antibody platform |
| WO2018136825A1 (en) * | 2017-01-19 | 2018-07-26 | Cedars-Sinai Medical Center | Highly multiplexed and mass spectrometry based methods to measuring 72 human proteins |
| MA49279A (fr) * | 2017-03-22 | 2020-02-05 | Hoffmann La Roche | Compositions d'anticorps optimisées pour le traitement de troubles oculaires |
| CA3083363A1 (en) * | 2017-12-01 | 2019-06-06 | Novartis Ag | Polyomavirus neutralizing antibodies |
-
2020
- 2020-08-21 US US17/637,349 patent/US20220306760A1/en not_active Abandoned
- 2020-08-21 WO PCT/US2020/047495 patent/WO2021041250A1/en not_active Ceased
- 2020-08-21 JP JP2022512306A patent/JP2022545682A/ja not_active Ceased
- 2020-08-21 CN CN202080059541.5A patent/CN114269380A/zh active Pending
- 2020-08-21 AU AU2020337333A patent/AU2020337333A1/en not_active Abandoned
- 2020-08-21 MX MX2022002239A patent/MX2022002239A/es unknown
- 2020-08-21 KR KR1020227008888A patent/KR20220050166A/ko active Pending
- 2020-08-21 CA CA3149350A patent/CA3149350A1/en active Pending
- 2020-08-21 BR BR112022003282A patent/BR112022003282A2/pt unknown
- 2020-08-21 EP EP20859308.7A patent/EP4017533A4/en active Pending
-
2022
- 2022-01-31 IL IL290253A patent/IL290253A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022545682A5 (https=) | ||
| JP7788113B2 (ja) | Ｃｈ３ドメインに基づくヘテロダイマー分子、その調製方法及び用途 | |
| ES3031036T3 (en) | Ch3 modified igg bispecific antibodies and processes for preparation | |
| ES2821753T3 (es) | Procedimientos de producción de Fab y de anticuerpos biespecíficos | |
| TWI359028B (en) | Bivalent, bispecific antibodies | |
| TWI359027B (en) | Bivalent, bispecific antibodies | |
| JP7138046B2 (ja) | 二特異性抗体基幹 | |
| JP6247673B2 (ja) | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 | |
| WO2018017863A1 (en) | Modified antigen-binding fab fragments and antigen-binding molecules comprising the same | |
| JP2020514277A5 (https=) | ||
| JP7679399B2 (ja) | 抗ｆｌｔ３抗体及び組成物 | |
| JP2024516098A5 (https=) | ||
| WO2021228091A1 (zh) | St2抗原结合蛋白 | |
| WO2022166977A1 (zh) | 抗人il-36r抗体及其应用 | |
| TWI857999B (zh) | 截斷的多價多元體 | |
| CN116199780A (zh) | TGF-β-RII结合蛋白质 | |
| JP2024546763A5 (https=) | ||
| JP2024546759A5 (https=) | ||
| WO2022148412A1 (zh) | 特异性结合cd47的抗体及其抗原结合片段 | |
| CN116867514A (zh) | 用于异二聚化的正交突变 | |
| JP2022517549A (ja) | 二価の二重特異性抗体およびその製造方法、コードする遺伝子、宿主細胞、組成物 | |
| ES3040852T3 (en) | Engineering charge pair mutations for pairing of hetero-igg molecules | |
| CN119546637A (zh) | 与FCγ受体的结合降低的嵌合重链恒定结构域及其用途 | |
| US20260098094A1 (en) | Cµ4 REGION FOR PAIRING HEAVY AND LIGHT CHAINS IN MULTI-SPECIFIC ANTIBODIES | |
| JP7498747B2 (ja) | 抗ｇｍ２ａｐ抗体及びその応用 |